Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; A Pneumocarr meeting report March 27-28, 2012, Geneva

David Goldblatt; Meena Ramakrishnan; Katherine O'Brien

Journal article

Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; A Pneumocarr meeting report March 27-28, 2012, Geneva

David Goldblatt, Meena Ramakrishnan, Katherine O'Brien

Vaccine | ELSEVIER SCI LTD | Published : 2013

DOI: 10.1016/j.vaccine.2013.06.040

University of Melbourne Researchers

Catherine Satzke Author Paediatrics Royal Children's Hospital

Grants

Awarded by National Institute for Health Research

Funding Acknowledgements

KOB: research grant support from Pfizer, and GlaxoSmithKline and has served on pneumococcal external expert committees convened by Merck, Aventis-pasteur, and GlaxoSmithKline.RD: grants/research support from Berna/Crucell, Wyeth/Pfizer, MSD, Protea; has been a scientific consultant for Berna/Crucell, GlaxoSmithKline, Novartis, Wyeth/Pfizer, Protea, MSD and a speaker for Berna/Crucell, GlaxoSmithKline, Wyeth/Pfizer; he is a shareholder of Protea/NASVAX.AS: has received research grant support from GSK and travel and accommodation support to attend a meeting convened by Merck.